World J Surg Oncol17 Oct 2025
A new meta-analysis shows the Albumin-Bilirubin (ALBI) score is crucial for predicting survival and liver function in hepatocellular carcinoma patients treated with transhepatic arterial chemoembolization (TACE).
BMC Surg16 Oct 2025
Preoperative and postoperative multidrug-resistant bacteria significantly impair recovery after pancreatic surgery.
Eur J Surg Oncol16 Oct 2025
Optimal lymphadenectomy and adjuvant capecitabine boost survival for gallbladder cancer patients.
Health Sci Rep16 Oct 2025
Pancreatic cancer in sub-Saharan Africa is largely diagnosed in advanced stages, severely affecting surgical outcomes.
Eur J Surg Oncol13 Oct 2025
A new model predicts postoperative complications in hepatectomy patients, helping surgeons identify high-risk individuals and improve outcomes.
HPB & Spleen12 Oct 2025
Single-port robotic liver resections are feasible and safe, even in moderate-volume centers.
Surg Endosc12 Oct 2025
Comparative study on endoscopic techniques reveals EPBD as superior for small common bile duct stones, impacting patient outcomes.
Hepatology11 Oct 2025
Laser-activated nanoparticles can enhance immune response by transforming the tumor microenvironment in cholangiocarcinoma.
Gastrointest Endosc11 Oct 2025
A new peptide haemostatic gel shows promise for controlling bleeding during EUS-guided drainage and direct endoscopic necrosectomy of pancreatic fluid collections.
Eur J Surg Oncol10 Oct 2025
Understanding non-tumor factors affecting surgery outcomes for colorectal liver metastases (CRLM) is crucial for reducing disparities.